Common DNA Methylation Dynamics in Endometriod Adenocarcinoma and Glioblastoma Suggest Universal Epigenomic Alterations in Tumorigenesis

Overview

Journal Commun Biol

Specialty Biology

Date 2021 May 22

PMID 34021236

Citations 6

Authors

Jennifer A Karlow

Benpeng Miao

Xiaoyun Xing

Ting Wang

Bo Zhang

Affiliations

Soon will be listed here.

Abstract

Trends in altered DNA methylation have been defined across human cancers, revealing global loss of methylation (hypomethylation) and focal gain of methylation (hypermethylation) as frequent cancer hallmarks. Although many cancers share these trends, little is known about the specific differences in DNA methylation changes across cancer types, particularly outside of promoters. Here, we present a comprehensive comparison of DNA methylation changes between two distinct cancers, endometrioid adenocarcinoma (EAC) and glioblastoma multiforme (GBM), to elucidate common rules of methylation dysregulation and changes unique to cancers derived from specific cells. Both cancers exhibit significant changes in methylation over regulatory elements. Notably, hypermethylated enhancers within EAC samples contain several transcription factor binding site clusters with enriched disease ontology terms highlighting uterine function, while hypermethylated enhancers in GBM are found to overlap active enhancer marks in adult brain. These findings suggest that loss of original cellular identity may be a shared step in tumorigenesis.

Citing Articles

Unveiling DNA methylation: early diagnosis, risk assessment, and therapy for endometrial cancer.

Li M, Xia Z, Wang R, Xi M, Hou M Front Oncol. 2025; 14:1455255.

PMID: 39902129 PMC: 11788147. DOI: 10.3389/fonc.2024.1455255.

Non-small Cell Lung Cancer Epigenomes Exhibit Altered DNA Methylation in Smokers and Never-smokers.

Karlow J, Pehrsson E, Xing X, Watson M, Devarakonda S, Govindan R Genomics Proteomics Bioinformatics. 2023; 21(5):991-1013.

PMID: 37742993 PMC: 10928376. DOI: 10.1016/j.gpb.2023.03.006.

Comprehensive analyses of partially methylated domains and differentially methylated regions in esophageal cancer reveal both cell-type- and cancer-specific epigenetic regulation.

Zheng Y, Ziman B, Ho A, Sinha U, Xu L, Li E Genome Biol. 2023; 24(1):193.

PMID: 37620896 PMC: 10463844. DOI: 10.1186/s13059-023-03035-3.

Oncogenic DNA methyltransferase 1 activates the PI3K/AKT/mTOR signalling by blocking the binding of HSPB8 and BAG3 in melanoma.

Yang Y, Ma S, Ye Z, Zheng Y, Zheng Z, Liu X Epigenetics. 2023; 18(1):2239607.

PMID: 37523636 PMC: 10392740. DOI: 10.1080/15592294.2023.2239607.

The DNA methylation landscape of five pediatric-tumor types.

Parker A, Quinteros B, Piccolo S PeerJ. 2022; 10:e13516.

PMID: 35707123 PMC: 9190670. DOI: 10.7717/peerj.13516.

References

Lander E, Linton L, Birren B, Nusbaum C, Zody M, Baldwin J . Initial sequencing and analysis of the human genome. Nature. 2001; 409(6822):860-921. DOI: 10.1038/35057062. View

Hoadley K, Yau C, Wolf D, Cherniack A, Tamborero D, Ng S . Multiplatform analysis of 12 cancer types reveals molecular classification within and across tissues of origin. Cell. 2014; 158(4):929-944. PMC: 4152462. DOI: 10.1016/j.cell.2014.06.049. View

Alexandrov L, Kim J, Haradhvala N, Huang M, Ng A, Wu Y . The repertoire of mutational signatures in human cancer. Nature. 2020; 578(7793):94-101. PMC: 7054213. DOI: 10.1038/s41586-020-1943-3. View

Hoadley K, Yau C, Hinoue T, Wolf D, Lazar A, Drill E . Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer. Cell. 2018; 173(2):291-304.e6. PMC: 5957518. DOI: 10.1016/j.cell.2018.03.022. View

Kandoth C, McLellan M, Vandin F, Ye K, Niu B, Lu C . Mutational landscape and significance across 12 major cancer types. Nature. 2013; 502(7471):333-339. PMC: 3927368. DOI: 10.1038/nature12634. View

Watson I, Takahashi K, Futreal P, Chin L . Emerging patterns of somatic mutations in cancer. Nat Rev Genet. 2013; 14(10):703-18. PMC: 4014352. DOI: 10.1038/nrg3539. View

Artez A, Bernabe R, Eerola I, Hemsley F, Jennings J, Kerr D . International network of cancer genome projects. Nature. 2010; 464(7291):993-8. PMC: 2902243. DOI: 10.1038/nature08987. View

Saghafinia S, Mina M, Riggi N, Hanahan D, Ciriello G . Pan-Cancer Landscape of Aberrant DNA Methylation across Human Tumors. Cell Rep. 2018; 25(4):1066-1080.e8. DOI: 10.1016/j.celrep.2018.09.082. View

McGhee J, Ginder G . Specific DNA methylation sites in the vicinity of the chicken beta-globin genes. Nature. 1979; 280(5721):419-20. DOI: 10.1038/280419a0. View

10.

Razin A, Cedar H . DNA methylation and gene expression. Microbiol Rev. 1991; 55(3):451-8. PMC: 372829. DOI: 10.1128/mr.55.3.451-458.1991. View

11.

Ball M, Li J, Gao Y, Lee J, LeProust E, Park I . Targeted and genome-scale strategies reveal gene-body methylation signatures in human cells. Nat Biotechnol. 2009; 27(4):361-8. PMC: 3566772. DOI: 10.1038/nbt.1533. View

12.

Shen H, Laird P . Interplay between the cancer genome and epigenome. Cell. 2013; 153(1):38-55. PMC: 3648790. DOI: 10.1016/j.cell.2013.03.008. View

13.

Feinberg A, Vogelstein B . Hypomethylation distinguishes genes of some human cancers from their normal counterparts. Nature. 1983; 301(5895):89-92. DOI: 10.1038/301089a0. View

14.

Baylin S, Herman J . DNA hypermethylation in tumorigenesis: epigenetics joins genetics. Trends Genet. 2000; 16(4):168-74. DOI: 10.1016/s0168-9525(99)01971-x. View

15.

Jones P, Baylin S . The fundamental role of epigenetic events in cancer. Nat Rev Genet. 2002; 3(6):415-28. DOI: 10.1038/nrg816. View

16.

Baylin S, Esteller M, Rountree M, Bachman K, Schuebel K, Herman J . Aberrant patterns of DNA methylation, chromatin formation and gene expression in cancer. Hum Mol Genet. 2001; 10(7):687-92. DOI: 10.1093/hmg/10.7.687. View

17.

Herman J, Latif F, Weng Y, Lerman M, Zbar B, Liu S . Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma. Proc Natl Acad Sci U S A. 1994; 91(21):9700-4. PMC: 44884. DOI: 10.1073/pnas.91.21.9700. View

18.

Dobrovic A, Simpfendorfer D . Methylation of the BRCA1 gene in sporadic breast cancer. Cancer Res. 1997; 57(16):3347-50. View

19.

Domann F, Rice J, Hendrix M, Futscher B . Epigenetic silencing of maspin gene expression in human breast cancers. Int J Cancer. 2000; 85(6):805-10. DOI: 10.1002/(sici)1097-0215(20000315)85:6<805::aid-ijc12>3.0.co;2-5. View

20.

Hovestadt V, Jones D, Picelli S, Wang W, Kool M, Northcott P . Decoding the regulatory landscape of medulloblastoma using DNA methylation sequencing. Nature. 2014; 510(7506):537-41. DOI: 10.1038/nature13268. View